SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Contract win

22 Mar 2019 07:00

RNS Number : 6581T
Oxford Instruments PLC
22 March 2019
 

Release date: 22 March 2019

Oxford Instruments and Chinese Academy of Sciences strengthen ties

 

Advanced cryogenic systems to be supplied to new laboratory facilities at the Chinese Academy's Institute of Physics

 

Oxford Instruments, a leading provider of high technology products and systems for industry and research, today announces winning the global tender to supply its market leading cryogenic equipment to the Institute of Physics-Chinese Academy of Sciences ("IOP-CAS") - a renowned research institute in fundamental study of condensed matter physics. Multiple advanced cryogenic systems will be installed at a new "Synergistic Extreme Conditions User Facility" at the Huairou Science City development in Beijing. This new collaboration further strengthens the long-standing relationship between Oxford Instruments and the IOIP-CAS, building on the performance and reliability of the many systems previously provided by Oxford Instruments to IOP-CAS's existing laboratories.

 

The supply agreement encompasses state-of-the-art superconducting magnet systems together with advanced dilution refrigerator systems, which will help to establish a world-leading synergetic user facility that integrates various extreme conditions. This will allow researchers to make ground breaking discoveries of new material states, states of matter and novel phenomena, furthering our understanding of the structure, properties and performance of these materials on a quantum scale. The complete suite of systems will be delivered to IOP-CAS in a staged plan through 2020 and 2021.

 

Ian Barkshire, Chief Executive of Oxford Instruments, commented: "This is an excellent example of the growth we are seeing from customers involved in Physical Science Research and Quantum Technologies where our key enabling technologies and advanced solutions enable fundamental research and accelerate our customers applied R&D. We are delighted to be the provider of choice to the renowned Institute of Physics in Beijing. This underlines Oxford Instruments' status as a world leader in state-of-the art technology solutions that create unique environments and enable measurements down to the molecular and atomic level."

 

- Ends -

Issued for and on behalf of Oxford Instruments plc

 

 

For further information please contact:

Oxford Instruments plc Tel: 01865 393200

Ian Barkshire, Chief Executive

Gavin Hill, Group Finance Director

 

MHP Communications Tel: 020 3128 8100

Rachel Hirst / Luke Briggs

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTJBMTTMBJTTTL
Date   Source Headline
25th Jul 20257:00 amPRNDirector/PDMR Shareholding
25th Jul 20257:00 amPRNTransaction in Own Shares
24th Jul 20257:00 amPRNTransaction in Own Shares
23rd Jul 20257:00 amPRNTransaction in Own Shares
22nd Jul 20257:00 amPRNTransaction in Own Shares
21st Jul 20257:00 amPRNTransaction in Own Shares
18th Jul 20257:00 amPRNTransaction in Own Shares
17th Jul 20257:00 amPRNTransaction in Own Shares
16th Jul 20257:00 amPRNTransaction in Own Shares
15th Jul 20257:00 amPRNTransaction in Own Shares
14th Jul 20257:00 amPRNTransaction in Own Shares
11th Jul 20251:35 pmPRNDirector/PDMR Shareholding
11th Jul 20257:00 amPRNTransaction in Own Shares
10th Jul 20257:00 amPRNTransaction in Own Shares
9th Jul 20257:00 amPRNTransaction in Own Shares
8th Jul 20257:00 amPRNTransaction in Own Shares
7th Jul 202510:30 amPRNHolding(s) in Company
7th Jul 20257:00 amPRNTransaction in Own Shares
4th Jul 20257:00 amPRNTransaction in Own Shares
3rd Jul 20257:00 amPRNTransaction in Own Shares
2nd Jul 20254:07 pmPRNDirector/PDMR Shareholding - purchase of shares
2nd Jul 20257:00 amPRNTransaction in Own Shares
1st Jul 202512:28 pmPRNBlocklisting - Interim Review
1st Jul 202512:28 pmPRNTotal Voting Rights
1st Jul 20257:00 amPRNTransaction in Own Shares
30th Jun 20257:00 amPRNTransaction in Own Shares
27th Jun 20257:00 amPRNTransaction in Own Shares
26th Jun 20252:02 pmPRNBlock Listing Application
26th Jun 20257:00 amPRNTransaction in Own Shares
25th Jun 202512:14 pmPRNPublication of Annual Report 2025 and Notice of Annual General Meeting 2025
25th Jun 20257:00 amPRNCommencement of Share Buyback
24th Jun 20259:30 amPRNHolding(s) in Company
20th Jun 20257:00 amPRNDirector/PDMR Shareholding
18th Jun 20254:30 pmPRNHolding(s) in Company
13th Jun 20257:00 amRNSPreliminary Results
12th Jun 20252:43 pmRNSAnnouncement of Preliminary Results
11th Jun 20252:38 pmPRNDirector/PDMR Shareholding
10th Jun 20254:12 pmPRNHolding(s) in Company
10th Jun 20257:00 amRNSDelay to announcement of preliminary results
10th Jun 20257:00 amRNSSale of Oxford Instruments’ quantum business
2nd Jun 202512:33 pmPRNTotal Voting Rights
13th May 20253:45 pmPRNDirector/PDMR Shareholding
22nd Apr 20253:40 pmPRNHolding(s) in Company
17th Apr 20251:40 pmPRNHolding(s) in Company
16th Apr 20257:00 amRNSTrading Update
15th Apr 20251:30 pmPRNHolding(s) in Company
14th Apr 20253:33 pmPRNDirector/PDMR Shareholding
10th Apr 20257:00 amRNSHolding(s) in Company
1st Apr 20257:00 amRNSTotal Voting Rights
25th Mar 202512:35 pmPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.